3

PRIMARY DOCUMENT

Company: ACADIA PHARMACEUTICALS INC
Filed: May 26, 2004
Period of Report: May 26, 2004
Accession Number: 0001179044-04-000095

View Document ↗ View on SEC.gov ↗